ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

KMK Kromek Group Plc

5.75
0.05 (0.88%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Kromek Group Plc LSE:KMK London Ordinary Share GB00BD7V5D43 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.05 0.88% 5.75 5.50 6.00 5.85 5.75 5.85 916,939 08:00:04
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Miscellaneous Metal Ores,nec 17.31M -6.1M -0.0102 -5.64 34.51M
Kromek Group Plc is listed in the Miscellaneous Metal Ores sector of the London Stock Exchange with ticker KMK. The last closing price for Kromek was 5.70p. Over the last year, Kromek shares have traded in a share price range of 3.15p to 8.55p.

Kromek currently has 600,247,000 shares in issue. The market capitalisation of Kromek is £34.51 million. Kromek has a price to earnings ratio (PE ratio) of -5.64.

Kromek Share Discussion Threads

Showing 3551 to 3569 of 7250 messages
Chat Pages: Latest  146  145  144  143  142  141  140  139  138  137  136  135  Older
DateSubjectAuthorDiscuss
14/6/2020
19:30
where's everybody gone!
abbynat
28/5/2020
18:02
But surely EVERYONE knows the quality of advice / view / opinion on these BBs is unsurpassed.....only the very best! So makes perfect sense to decide buy / hold or sell......
jaf111
28/5/2020
17:46
Looks interesting, need to do some research on this.

Eye out for now...
Thanks all,

D

dennisbergkamp
28/5/2020
16:10
Ventilators could set this year’s sales ablaze
Just when Kromek’s hands should have been full with all that, Kromek is now turning to making ventilators to assist the global response to COVID-19 and has licenced-in a design from Metran, a leading Japanese ventilator company.
The re-tooling of Kromek's existing production facilities to make a ventilator is not expected to incur any material cost and Kromek reckons it can produce up to 2,000 units within the first twelve weeks, which will benefit the current year sales starting 1 May. With an average selling price of ventilators around the US$10k mark, 2,000 units could see this agreement producing a US$20m revenue contribution, which is yet to be factored into broker forecasts.
Interestingly broker Cenkos says, “it does not expect a material diversion of resources away from the core activities,” which are alone expected to generate sales of £18.5m, ebitda of £4.2m and a pretax loss of £0.3m this year - before any contribution from the ventilators business.
Kromek has the classic characteristic of a successful technology business. It could become highly cash generative as volumes scale up across the board (the 55% gross margin on traditional business results in a high drop through).

malcolmmm
28/5/2020
15:22
I no the UK factory at Netpark Sedgefield is definitely working.
1luckylee
28/5/2020
15:08
Been catching up here to see if I should buy or sell- at the moment the shares to me seem correctly priced so do not plan to do anything.
One question
Does anyone know if their factories in the US and the UK are working??. One assumes they are busy producing ventilators but apart from comments about supply hold ups they have been coy in both the March 26 statement on their website as well as the RNS as to what is happening in the factories.

cerrito
28/5/2020
14:21
well done malcommm! i sit here corrected! i take back anything i posted previously or will post in the future!
if that makes any sense!
cheers, good post. one of the better ones!

abbynat
28/5/2020
10:57
Hmm - just dropped in here because the idea of something that can detect airborne pathogens sounds hugely exciting. But then I look at the recent TU and not even a mention.

It either does not do what I thought it could, or the company has no confidence around the sensitivity, specificity or efficacy. ie it is not reliable.

melody9999
28/5/2020
10:54
Yesterday I was sent an email update from another source recommending them again after the recent news. I will post it if anyone is interested later today.I bought more on the news and intend to hold for at least a 100% rise, seems a good one to keep for a couple of years.
malcolmmm
28/5/2020
10:11
so you bought in @18, no doubt you will be off when you can sell for 24 or 25!
whats the point of your post?

abbynat
28/5/2020
07:47
Huge potential imo in the circumstances, bought in at 18p on a SCSW tip
malcolmmm
27/5/2020
08:29
Buywell, the point is not that it will be used in ICU's, but it could make much more sense to use at the entrance to A&E departments or in operating theatres as I suspect you well know - but it's always good to belittle a reasoned post on a board. It will be clearly be much more useful in detecting concentrations of virus in different cities or different public places within cities.
18bt
27/5/2020
07:36
Lol this is the upside down company... good news is met with a fat red candle. Well, bought and sold early for a nice little gain but I retain a decent core holding here, one of my favourite longer term plays all imo dyor ofc
rathean
27/5/2020
07:02
18BT

An ICU room in any Hospital these days will be full of Covid-19 virus

You don't need a machine to tell you that

Try again

buywell3
27/5/2020
06:57
It does look really exciting news as DARPA in US gives $5.2m extension to the bio-threat detection project started in 2018. Once finished this solution can speedily genetically code samples = a revolution in pathogen detection, and much needed

Read research note out from Equity Development:

edmonda
27/5/2020
06:35
In the very least, over £4m of contract value in the next year is significant for a company with forecast turnover of £14.5m for YE 4/2020. They really need to get some forecasts out there for 2021.
18bt
27/5/2020
06:32
They've been very careful not to mention COVID-19 in this morning's announcement, but the mention of hospitals clearly foreshadows this. Being able to pick up viruses and gene sequence them and geo locate them is hugely powerful and would be hugely in demand. But can they get it to work? There ouht to be a significant option value on the shares with this announcement.
18bt
15/5/2020
08:20
Doubled up this morning.Sure the market is in puke mode but I like the story here, intellectual moat and high cost of entry into its core markets... and of course it's continued work on a mobile pathogen device that could revolutionise real time population healthcare and security.All imo dyor ofc!
rathean
11/5/2020
12:53
MMMMmmmmmmmmm
middlesboroughfc
Chat Pages: Latest  146  145  144  143  142  141  140  139  138  137  136  135  Older

Your Recent History

Delayed Upgrade Clock